Quick Takeaways
- EcoR1 Capital, LLC filed SCHEDULE 13G/A for iTeos Therapeutics, Inc. Common Stock (ITOS).
- Disclosed ownership: 15%.
- Date of event: 13 May 2025.
EcoR1 Capital, LLC - 13 May 2025 SCHEDULE 13G/A Report for iTeos Therapeutics, Inc. Common Stock (ITOS)
- Filing Manager
- EcoR1 Capital, LLC
- Reporting Manager
- EcoR1 Capital, LLC
- Symbol
- ITOS
- Shares outstanding
- 38,456,376 shares
- Disclosed Ownership
- 5,730,000 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 May 2025, 19:10:26 UTC
- Date of event
- 13 May 2025
- Previous filing
- 08 May 2025
- Next filing
- 16 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"EcoR1 Capital, LLC disclosed 15% ownership in iTeos Therapeutics, Inc. Common Stock (ITOS) on 13 May 2025."
What Changed
- Previous schedule filing date: 08 May 2025.
- Current filing was accepted on 13 May 2025, 19:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 15% | 5,730,000 | 0 | 5,730,000 | /s/ Oleg Nodelman | Manager | |
| Oleg Nodelman | 15% | 5,730,000 | 0 | 5,730,000 | /s/ Oleg Nodelman | Reporting person | |
| EcoR1 Capital Fund Qualified, L.P. | 14% | 5,371,661 | 0 | 5,371,661 | /s/ Oleg Nodelman | Manager of the General Partner, EcoR1 Capital, LLC |